C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of CD44 mRNA | 19933214 |
C104564 | 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine | 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in decreased expression of CD44 protein | 19997594 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl affects the expression of CD44 mRNA" | 20638727 |
C530773 | 3,5-diethoxycarbonyl-1,4-dihydrocollidine | "3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of CD44 mRNA" | 27052460 |
C530773 | 3,5-diethoxycarbonyl-1,4-dihydrocollidine | "SULT2B1 protein promotes the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of CD44 mRNA]" | 27052460 |
C048460 | 3-deazaneplanocin | [3-deazaneplanocin co-treated with trichostatin A] affects the expression of CD44 protein | 18538736 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of CD44 mRNA" | 18648102 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of CD44 mRNA" | 18289764 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of CD44 mRNA | 19191707 |
C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide affects the expression of CD44 mRNA | 20829426 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CD44 mRNA | 25458485 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CD44 mRNA | 27761495|2906747 |
D000082 | Acetaminophen | CD44 gene polymorphism results in increased susceptibility to Acetaminophen | 19416960 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of CD44 mRNA | 23358195 |
D000082 | Acetaminophen | CD44 gene polymorphism results in increased susceptibility to Acetaminophen | 19416960 |
D000082 | Acetaminophen | CD44 polymorphism results in increased susceptibility to Acetaminophen | 22940726 |
D000082 | Acetaminophen | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | 25607892 |
D000171 | Acrolein | Acrolein results in increased expression of CD44 mRNA | 18515264 |
D020106 | Acrylamide | Acrylamide results in decreased expression of CD44 mRNA | 28959563 |
C096064 | actein | actein results in increased expression of CD44 mRNA | 19527300 |
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of CD44 protein | 20106945 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CD44 mRNA | 22100608|2715375 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of CD44 gene | 27153756 |
D000420 | Albuterol | Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]] | 18076728 |
D000420 | Albuterol | Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] | 18076728 |
D013196 | Dihydrotestosterone | Dihydrotestosterone results in increased expression of CD44 protein | 23936228 |
D013196 | Dihydrotestosterone | SHBG affects the reaction [Dihydrotestosterone results in increased expression of CD44 protein] | 23936228 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CD44 mRNA | 16483693 |
C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of CD44 mRNA" | 22863853 |
D000726 | Androgen Antagonists | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | 25607892 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CD44 mRNA | 24449571 |
D001151 | Arsenic | Arsenic results in decreased expression of CD44 mRNA | 16835338 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CD44 mRNA | 19804631 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CD44 mRNA alternative form | 22391160 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CD44 protein | 15553829 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CD44 protein alternative form | 22391160|2309847 |
C006632 | arsenic trioxide | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CD44 mRNA | 15894607 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CD44 mRNA" | 12839939|2416032 |
D017638 | Asbestos, Crocidolite | "FOSL1 protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CD44 mRNA]" | 12839939 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CD44 mRNA" | 12839939 |
D017638 | Asbestos, Crocidolite | "FOSL1 protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CD44 mRNA]" | 12839939 |
D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA | 23692848 |
D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein | 23692848 |
D001205 | Ascorbic Acid | CAT protein inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA] | 23692848 |
D001205 | Ascorbic Acid | CAT protein inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein] | 23692848 |
D001205 | Ascorbic Acid | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA]" | 23692848 |
D001205 | Ascorbic Acid | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]" | 23692848 |
D001241 | Aspirin | Aspirin results in decreased expression of CD44 protein alternative form | 16878161 |
D001241 | Aspirin | CTNNB1 affects the reaction [Aspirin results in decreased expression of CD44 protein alternative form] | 16878161 |
D001241 | Aspirin | Aspirin results in decreased expression of CD44 mRNA | 12800193 |
C406592 | azaspiracid | azaspiracid results in increased expression of CD44 mRNA | 28939011 |
D001414 | Bacitracin | Bacitracin results in increased expression of CD44 mRNA | 18289764 |
C028559 | bathocuproine sulfonate | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA] | 15477007 |
D001507 | Beclomethasone | Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]] | 18076728 |
D001507 | Beclomethasone | Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] | 18076728 |
D001507 | Beclomethasone | Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein] | 18076728 |
D001507 | Beclomethasone | Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein] | 18076728 |
D001507 | Beclomethasone | Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]] | 18076728 |
D001507 | Beclomethasone | Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] | 18076728 |
D001554 | Benzene | Benzene affects the expression of CD44 mRNA | 21147609 |
D001554 | Benzene | Benzene results in increased expression of CD44 mRNA | 15929907 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased splicing of CD44 mRNA | 20097212 |
D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of CD44 mRNA | 26271895 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CD44 mRNA | 19770486 |
C020711 | beryllium sulfate | beryllium sulfate results in increased expression of CD44 mRNA | 16314022 |
D004958 | Estradiol | Estradiol affects the expression of CD44 mRNA | 25321415 |
D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CD44 mRNA | 19619570 |
D004958 | Estradiol | Estradiol results in increased expression of CD44 mRNA | 19167446|1961957 |
D004958 | Estradiol | Estradiol results in increased expression of CD44 protein | 16912569 |
D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of CD44 mRNA | 20226447 |
D001622 | Betaine | Betaine results in decreased expression of CD44 mRNA | 26391144 |
C044887 | beta-methylcholine | beta-methylcholine affects the expression of CD44 mRNA | 21179406 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CD44 mRNA | 20678512|2257669 |
C006780 | bisphenol A | bisphenol A results in increased expression of CD44 mRNA | 18007998|2654697 |
C006780 | bisphenol A | bisphenol A affects the expression of CD44 mRNA | 25181051 |
C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | 25607892 |
C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CD44 mRNA | 25607892 |
C006780 | bisphenol A | bisphenol A results in increased methylation of CD44 gene | 28505145 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of CD44 mRNA | 21601586 |
D002084 | Butylated Hydroxytoluene | [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of CD44 mRNA alternative form | 15390079 |
C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | 25607892 |
C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CD44 mRNA | 25607892 |
D020148 | Butyric Acid | Butyric Acid affects the expression of CD44 mRNA | 12800193 |
D002104 | Cadmium | Cadmium results in increased expression of CD44 mRNA | 22626610 |
D002104 | Cadmium | Cadmium results in increased expression of CD44 protein | 22626610 |
C459604 | candoxin | candoxin results in increased expression of CD44 mRNA | 16309724 |
D002220 | Carbamazepine | Carbamazepine affects the expression of CD44 mRNA | 25979313 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CD44 mRNA | 17484886|2733941 |
D002251 | Carbon Tetrachloride | CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of IFNG mRNA] | 18395288 |
D002251 | Carbon Tetrachloride | CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of IL1A mRNA] | 18395288 |
D002251 | Carbon Tetrachloride | CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA] | 18395288 |
D002251 | Carbon Tetrachloride | CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of LTB mRNA] | 18395288 |
D002251 | Carbon Tetrachloride | CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA] | 18395288 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of CD44 mRNA | 12734012 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CD44 protein | 12629582 |
D002330 | Carmustine | CD44 mRNA affects the susceptibility to Carmustine | 16365179 |
D002713 | Chlorine | [Ozone co-treated with Chlorine] affects the expression of CD44 mRNA | 18636392 |
D002726 | Chlorogenic Acid | Chlorogenic Acid results in increased expression of CD44 mRNA | 20706672 |
D002746 | Chlorpromazine | Chlorpromazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] | 9929743 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD44 mRNA | 20938992 |
C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of CD44 mRNA | 28472532 |
D002939 | Ciprofloxacin | Ciprofloxacin results in increased expression of CD44 protein | 26947806 |
C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CD44 mRNA | 19376846|2294125 |
C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CD44 protein | 16798617|2484233 |
C018021 | cobaltous chloride | [EPAS1 protein results in increased susceptibility to cobaltous chloride] which results in increased expression of CD44 mRNA | 25805230 |
C018021 | cobaltous chloride | [HIF1A protein results in increased susceptibility to cobaltous chloride] which results in increased expression of CD44 mRNA | 25805230 |
C018021 | cobaltous chloride | triptolide inhibits the reaction [cobaltous chloride results in increased expression of CD44 protein] | 24842335 |
D003042 | Cocaine | Cocaine results in decreased expression of CD44 mRNA | 18000554 |
D003078 | Colchicine | Colchicine results in increased expression of CD44 mRNA | 20624997 |
D003300 | Copper | Copper deficiency results in increased expression of CD44 mRNA | 26033743 |
D003300 | Copper | Copper results in increased expression of CD44 mRNA | 22465980 |
D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of CD44 mRNA | 19167446 |
D003375 | Coumestrol | Coumestrol results in increased expression of CD44 mRNA | 19167446 |
C551994 | crizotinib | crizotinib results in decreased expression of CD44 mRNA | 22973962 |
C551994 | crizotinib | crizotinib results in decreased expression of CD44 protein | 22973962 |
D003471 | Cuprizone | Cuprizone results in increased expression of CD44 mRNA | 27523638 |
D003474 | Curcumin | Curcumin results in increased expression of CD44 mRNA | 15713895 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein] | 9929743 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CD44 mRNA | 20106945 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CD44 mRNA | 19770486 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CD44 mRNA | 21865292 |
D003561 | Cytarabine | Cytarabine results in decreased expression of CD44 mRNA | 21198554 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of CD44 mRNA | 23640034 |
C014347 | decitabine | decitabine affects the expression of CD44 mRNA | 23300844 |
C014347 | decitabine | decitabine results in increased expression of CD44 mRNA | 27915011 |
C107676 | deguelin | deguelin results in decreased expression of CD44 mRNA | 26884827 |
C107676 | deguelin | deguelin results in decreased expression of CD44 protein | 26884827 |
D003703 | Demecolcine | Demecolcine results in increased expression of CD44 mRNA | 23649840 |
D016264 | Dextran Sulfate | [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of CD44 mRNA | 26271895 |
D016190 | Carboplatin | Carboplatin results in decreased expression of CD44 mRNA | 18172885 |
D003976 | Diazinon | Diazinon results in increased methylation of CD44 gene | 22964155 |
D003993 | Dibutyl Phthalate | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of CD44 mRNA | 21266533 |
D002945 | Cisplatin | CD44 gene mutant form results in decreased susceptibility to Cisplatin | 21471434 |
D002945 | Cisplatin | CD44 protein results in decreased susceptibility to Cisplatin | 21124918 |
D002945 | Cisplatin | Cisplatin affects the expression of CD44 mRNA | 23300844 |
D002945 | Cisplatin | Cisplatin results in increased expression of CD44 mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in increased expression of CD44 protein | 21618587 |
D002945 | Cisplatin | Cisplatin results in increased expression of CD44 mRNA | 21151649 |
D002945 | Cisplatin | Cisplatin results in increased expression of CD44 mRNA | 18289764 |
D003633 | Dichlorodiphenyl Dichloroethylene | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D004008 | Diclofenac | Diclofenac results in increased expression of CD44 mRNA | 26934552 |
D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in increased expression of CD44 mRNA | 15784690 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CD44 mRNA | 18042831 |
D019422 | Dietary Sucrose | Dietary Sucrose results in increased expression of CD44 mRNA | 26033743 |
D004051 | Diethylhexyl Phthalate | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CD44 mRNA | 21527772 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CD44 protein | 27058323 |
D004052 | Diethylnitrosamine | epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CD44 protein] | 27058323 |
D004052 | Diethylnitrosamine | theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CD44 protein] | 27058323 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CD44 mRNA | 19638242 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CD44 mRNA | 26865669 |
D002117 | Calcitriol | Calcitriol results in decreased expression of CD44 | 16051482 |
C472511 | dimethylarsinous acid | dimethylarsinous acid results in increased expression of CD44 mRNA | 20886546 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of CD44 protein | 14643895 |
C051904 | dinophysistoxin 1 | dinophysistoxin 1 results in increased expression of CD44 mRNA | 28939011 |
D004237 | Diuron | Diuron results in increased expression of CD44 mRNA | 21551480 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CD44 mRNA | 16705698 |
D004317 | Doxorubicin | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin | 19047049 |
D004317 | Doxorubicin | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D004317 | Doxorubicin | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D004317 | Doxorubicin | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin | 19047049 |
D004317 | Doxorubicin | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D004317 | Doxorubicin | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D004317 | Doxorubicin | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin] | 19047049 |
D004317 | Doxorubicin | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin] | 19047049 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of CD44 mRNA" | 23262642 |
D004391 | Dust | Dust results in increased expression of CD44 mRNA | 17805423 |
C118739 | entinostat | entinostat results in increased expression of CD44 mRNA | 26272509 |
C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | 25607892 |
C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CD44 mRNA | 25607892 |
D004791 | Enzyme Inhibitors | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CD44 protein | 23301498 |
C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CD44 protein] | 27058323 |
C109476 | epoxiconazole | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CD44 mRNA | 12655037 |
D008656 | Mestranol | Mestranol results in increased expression of CD44 mRNA | 26865669 |
D017308 | Etodolac | Etodolac results in decreased expression of CD44 protein | 16046235 |
D005047 | Etoposide | CD44 protein affects the susceptibility to Etoposide | 15215046 |
D005047 | Etoposide | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide | 19047049 |
D005047 | Etoposide | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D005047 | Etoposide | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D005047 | Etoposide | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide | 19047049 |
D005047 | Etoposide | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D005047 | Etoposide | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D005047 | Etoposide | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide] | 19047049 |
D005047 | Etoposide | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide] | 19047049 |
C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of CD44 mRNA | 18055543 |
C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of CD44 protein | 18055543 |
C020748 | ferrous sulfate | [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA | 23692848 |
C020748 | ferrous sulfate | [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein | 23692848 |
C020748 | ferrous sulfate | CAT protein inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA] | 23692848 |
C020748 | ferrous sulfate | CAT protein inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein] | 23692848 |
C020748 | ferrous sulfate | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA]" | 23692848 |
C020748 | ferrous sulfate | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]" | 23692848 |
D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CD44 mRNA | 17187413|2258468 |
D005472 | Fluorouracil | [gimeracil co-treated with Fluorouracil] results in decreased expression of CD44 | 12364819 |
D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD44 mRNA | 20938992 |
D005557 | Formaldehyde | Formaldehyde results in decreased expression of CD44 mRNA | 20655997 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of CD44 mRNA | 23649840 |
D000068759 | Formoterol Fumarate | Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]] | 18076728 |
D000068759 | Formoterol Fumarate | Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] | 18076728 |
C070081 | fulvestrant | fulvestrant results in decreased expression of CD44 mRNA | 26865669 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Genistein results in increased expression of CD44 mRNA] | 22553218 |
C039281 | furan | furan results in increased expression of CD44 mRNA | 27387713 |
D019833 | Genistein | Genistein results in decreased expression of CD44 mRNA | 16705744 |
D019833 | Genistein | Genistein results in increased expression of CD44 mRNA | 20706672|2686566 |
D019833 | Genistein | fulvestrant inhibits the reaction [Genistein results in increased expression of CD44 mRNA] | 22553218 |
D019833 | Genistein | Genistein results in increased expression of CD44 mRNA | 22553218 |
D005839 | Gentamicins | Gentamicins results in increased expression of CD44 mRNA | 22061828 |
D005839 | Gentamicins | Gentamicins results in increased expression of CD44 protein | 11231351 |
C104201 | gimeracil | [gimeracil co-treated with Fluorouracil] results in decreased expression of CD44 | 12364819 |
D005947 | Glucose | Glucose results in increased expression of CD44 mRNA | 17178593 |
C004312 | glycidol | glycidol results in decreased expression of CD44 mRNA | 24915197 |
C010974 | glyphosate | glyphosate results in increased expression of CD44 mRNA | 28711546 |
C010176 | halofuginone | halofuginone results in increased expression of CD44 mRNA | 17180598 |
C014026 | hexamethylene bisacetamide | hexamethylene bisacetamide results in decreased expression of CD44 mRNA | 17349212 |
D006589 | Hexestrol | Hexestrol results in increased expression of CD44 mRNA | 26865669 |
D006820 | Hyaluronic Acid | Hyaluronic Acid analog binds to and results in increased activity of CD44 protein | 12402308 |
D006820 | Hyaluronic Acid | [Hyaluronic Acid analog binds to and results in increased activity of CD44 protein] which results in increased expression of PLAU mRNA | 12402308 |
D006820 | Hyaluronic Acid | [Hyaluronic Acid analog binds to and results in increased activity of CD44 protein] which results in increased expression of PLAU protein | 12402308 |
D006820 | Hyaluronic Acid | [Hyaluronic Acid analog binds to and results in increased activity of CD44 protein] which results in increased expression of PLAUR mRNA | 12402308 |
D006820 | Hyaluronic Acid | [Hyaluronic Acid analog binds to and results in increased activity of CD44 protein] which results in increased expression of PLAUR protein | 12402308 |
D006820 | Hyaluronic Acid | Hyaluronic Acid binds to CD44 protein | 19047049 |
D006820 | Hyaluronic Acid | [Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein | 19047049 |
D006820 | Hyaluronic Acid | [[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA | 19047049 |
D006820 | Hyaluronic Acid | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA] | 19047049 |
D006820 | Hyaluronic Acid | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] | 19047049 |
D006820 | Hyaluronic Acid | Hyaluronic Acid analog affects the localization of [MAP3K1 protein binds to CD44 protein] | 20159036 |
D006820 | Hyaluronic Acid | Hyaluronic Acid analog promotes the reaction [MAP3K1 protein binds to CD44 protein] | 20159036 |
D006820 | Hyaluronic Acid | Hyaluronic Acid metabolite results in increased expression of CD44 mRNA | 23692848 |
D006820 | Hyaluronic Acid | Hyaluronic Acid metabolite results in increased expression of CD44 protein | 23692848 |
D006820 | Hyaluronic Acid | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Hyaluronic Acid metabolite results in increased expression of CD44 mRNA]" | 23692848 |
D006820 | Hyaluronic Acid | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Hyaluronic Acid metabolite results in increased expression of CD44 protein]" | 23692848 |
D006820 | Hyaluronic Acid | Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid] | 9929743 |
D006820 | Hyaluronic Acid | Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid]] | 9929743 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of CD44 mRNA | 20044591 |
D006861 | Hydrogen Peroxide | [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD44 mRNA | 24489904 |
C475919 | hydroxytamoxifen | hydroxytamoxifen results in increased expression of CD44 mRNA | 16849584 |
D006923 | Hymecromone | Hymecromone results in decreased expression of CD44 mRNA | 23139787 |
D007213 | Indomethacin | Indomethacin results in increased expression of CD44 mRNA | 16771604 |
D015759 | Ionomycin | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA] | 15477007 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA | 15477007 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CD44 mRNA | 25613284 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CD44 mRNA | 25961927 |
C006552 | kaempferol | kaempferol inhibits the reaction [IL32 protein results in increased expression of CD44 protein] | 28711657 |
C006552 | kaempferol | kaempferol inhibits the reaction [APOE affects the expression of CD44 mRNA] | 22005275 |
C006552 | kaempferol | kaempferol inhibits the reaction [APOE affects the expression of CD44 protein] | 22005275 |
D048628 | Ketolides | Ketolides analog results in increased expression of CD44 mRNA | 24967691 |
C490728 | lapatinib | [lapatinib results in decreased susceptibility to lapatinib] which results in increased expression of CD44 protein | 26643609 |
C052901 | lemongrass oil | lemongrass oil affects the expression of CD44 mRNA | 25976427 |
C052901 | lemongrass oil | lemongrass oil results in decreased expression of CD44 mRNA | 25660481 |
D008044 | Linuron | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CD44 mRNA | 27339419 |
D018021 | Lithium Chloride | Lithium Chloride results in increased expression of CD44 mRNA | 23527032 |
D008148 | Lovastatin | Lovastatin results in decreased expression of CD44 mRNA | 21199873 |
D008148 | Lovastatin | Lovastatin results in decreased expression of CD44 protein | 21199873 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA | 26378955 |
D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD44 mRNA | 21641980 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA | 26378955 |
C011907 | melamine | melamine results in increased expression of CD44 | 23052191 |
C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
D008701 | Methapyrilene | Methapyrilene results in increased expression of CD44 protein | 28935588 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD44 mRNA | 20938992 |
D008731 | Methoxychlor | Methoxychlor affects the expression of CD44 mRNA | 20829426 |
D008748 | Methylcholanthrene | [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of CD44 mRNA alternative form | 15390079 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CD44 mRNA | 20713471 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CD44 mRNA | 28001369 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of CD44 mRNA | 23649840 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD44 mRNA" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CD44 mRNA" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD44 mRNA]" | 20230807 |
C008493 | methylselenic acid | methylselenic acid results in decreased expression of CD44 mRNA | 12517777 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CD44 protein] | 21199873 |
D015735 | Mifepristone | Mifepristone results in increased expression of CD44 mRNA | 19439560 |
C502230 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 mRNA]" | 23692848 |
C502230 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]" | 23692848 |
C502230 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Hyaluronic Acid metabolite results in increased expression of CD44 mRNA]" | 23692848 |
C502230 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Hyaluronic Acid metabolite results in increased expression of CD44 protein]" | 23692848 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CD44 mRNA | 25145660 |
C500085 | muraglitazar | muraglitazar results in decreased expression of CD44 mRNA | 21515302 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CD44 mRNA | 15674843|1895507 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of CD44 mRNA" | 23845593 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of CD44 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CD44 mRNA" | 25554681 |
C000621033 | napabucasin | napabucasin results in decreased expression of CD44 mRNA | 25605917 |
D009532 | Nickel | Nickel affects the expression of CD44 mRNA | 14575637 |
D009532 | Nickel | Nickel results in increased expression of CD44 mRNA | 24768652|2558310 |
D009532 | Nickel | trichostatin A inhibits the reaction [Nickel affects the expression of CD44 mRNA] | 14575637 |
C022838 | nickel chloride | nickel chloride results in increased expression of CD44 protein | 26962057 |
D009538 | Nicotine | "[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CD44 mRNA" | 20230807 |
D009538 | Nicotine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD44 mRNA]" | 20230807 |
C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of CD44 mRNA | 17616710 |
C025589 | ochratoxin A | ochratoxin A results in increased expression of CD44 mRNA | 23358140 |
C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | 25607892 |
C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CD44 mRNA | 25607892 |
D019319 | Okadaic Acid | Okadaic Acid results in increased expression of CD44 mRNA | 28939011 |
C507134 | ON 01910 | ON 01910 results in increased expression of CD44 mRNA | 22351695 |
C485800 | osajin | osajin results in increased expression of CD44 mRNA | 20706672 |
C472349 | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of CD44 mRNA | 17655762 |
C472349 | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Particulate Matter affects the expression of CD44 mRNA] | 17655762 |
C472349 | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Vehicle Emissions affects the expression of CD44 mRNA] | 17655762 |
C472349 | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine | Particulate Matter promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of CD44 mRNA] | 17655762 |
C472349 | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine | Vehicle Emissions promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of CD44 mRNA] | 17655762 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of CD44 protein | 25351418 |
D010100 | Oxygen | vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CD44 protein] | 26305601 |
D010126 | Ozone | Ozone results in increased expression of CD44 mRNA | 12763052 |
D010126 | Ozone | [Ozone co-treated with Chlorine] affects the expression of CD44 mRNA | 18636392 |
D000073878 | Palm Oil | Palm Oil results in increased expression of CD44 mRNA | 18042831 |
C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
C496932 | panobinostat | panobinostat results in increased expression of CD44 mRNA | 26272509 |
D010269 | Paraquat | Paraquat results in decreased expression of CD44 mRNA | 18198484 |
D052638 | Particulate Matter | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Particulate Matter affects the expression of CD44 mRNA] | 17655762 |
D052638 | Particulate Matter | Particulate Matter affects the expression of CD44 mRNA | 17655762 |
D052638 | Particulate Matter | Particulate Matter promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of CD44 mRNA] | 17655762 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CD44 mRNA | 28846189 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CD44 protein | 28846189 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CD44 mRNA | 21708214 |
C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of CD44 mRNA | 26705709 |
D010634 | Phenobarbital | Phenobarbital affects the expression of CD44 mRNA | 19159669 |
D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CD44 mRNA] | 19482888 |
D010634 | Phenobarbital | Phenobarbital affects the expression of CD44 mRNA | 23091169 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of CD44 mRNA | 19482888 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of CD44 mRNA | 26272509 |
D010862 | Pilocarpine | Pilocarpine results in increased expression of CD44 protein | 15191797 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of CD44 mRNA | 17426115|2081375 |
D010894 | Piroxicam | Piroxicam results in increased expression of CD44 mRNA | 21858171 |
D010936 | Plant Extracts | HOTAIR mutant form inhibits the reaction [Plant Extracts analog results in increased expression of CD44 mRNA] | 25447409 |
D010936 | Plant Extracts | Plant Extracts analog results in increased expression of CD44 mRNA | 25447409 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of CD44 mRNA | 23262642 |
C474837 | pomiferin | pomiferin results in increased expression of CD44 mRNA | 20706672 |
C045362 | prochloraz | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
C035988 | procymidone | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D011374 | Progesterone | Progesterone results in decreased expression of CD44 mRNA | 23012394 |
D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of CD44 mRNA | 20226447 |
D011374 | Progesterone | Progesterone results in decreased expression of CD44 mRNA | 18692832 |
D011374 | Progesterone | Progesterone results in increased expression of CD44 mRNA | 22238285 |
D011374 | Progesterone | Progesterone results in decreased expression of CD44 mRNA | 20726854 |
D011374 | Progesterone | Progesterone results in increased expression of CD44 mRNA | 21770760 |
C045950 | propiconazole | propiconazole results in increased expression of CD44 mRNA | 21278054 |
D011429 | Propolis | Propolis results in increased expression of CD44 mRNA | 20706672 |
D011441 | Propylthiouracil | Propylthiouracil results in increased expression of CD44 mRNA | 24780913 |
D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside results in increased expression of CD44 protein | 8635280 |
C020972 | pyrrolidine dithiocarbamic acid | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA] | 15477007 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in decreased expression of CD44 mRNA | 26865669 |
D017382 | Reactive Oxygen Species | [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD44 mRNA | 24489904 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in decreased expression of CD44 protein | 21833471 |
C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of CD44 mRNA | 19167446 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA] | 19047049 |
C059514 | resveratrol | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] | 19047049 |
C059514 | resveratrol | resveratrol results in decreased expression of CD44 protein | 22692956 |
C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD44 protein] | 20715097 |
C059514 | resveratrol | resveratrol results in decreased expression of CD44 protein | 25505154 |
C089730 | rosiglitazone | rosiglitazone affects the expression of CD44 mRNA | 21515302 |
D012643 | Selenium | Selenium inhibits the reaction [T-2 Toxin results in decreased expression of CD44 protein] | 18196609 |
D012643 | Selenium | Selenium results in increased expression of CD44 mRNA | 18196609 |
D012643 | Selenium | Selenium results in increased expression of CD44 protein | 18196609 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CD44 mRNA" | 21514415 |
C112356 | seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide | seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CD44 protein] | 11717450 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CD44 mRNA | 19073995|2322117 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CD44 mRNA | 21602193 |
D019821 | Simvastatin | Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CD44 protein] | 21199873 |
D019821 | Simvastatin | Simvastatin promotes the reaction [TP53 protein binds to CD44 promoter] | 21199873 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CD44 mRNA | 21199873 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CD44 protein | 21199873 |
D012906 | Smoke | HOTAIR mutant form inhibits the reaction [Smoke analog results in increased expression of CD44 mRNA] | 25447409 |
D012906 | Smoke | Smoke analog results in increased expression of CD44 mRNA | 25447409|2552692 |
D012906 | Smoke | Smoke results in increased expression of CD44 mRNA | 21095227 |
C017947 | sodium arsenite | sodium arsenite affects the methylation of CD44 gene | 28589171 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of CD44 mRNA | 25879800 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CD44 protein | 23549458 |
C017947 | sodium arsenite | sodium arsenite results in increased stability of CD44 mRNA | 25493608 |
C016104 | sodium bichromate | sodium bichromate results in increased expression of CD44 mRNA | 22561333 |
D012999 | Soman | Soman results in increased expression of CD44 mRNA | 19281266 |
D053260 | Soot | Soot results in increased expression of CD44 mRNA | 22461453 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA | 26378955 |
D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD44 mRNA | 21641980 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA | 26378955 |
D013605 | T-2 Toxin | Selenium inhibits the reaction [T-2 Toxin results in decreased expression of CD44 protein] | 18196609 |
D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of CD44 mRNA | 18196609 |
D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of CD44 protein | 18196609 |
D016559 | Tacrolimus | Tacrolimus results in increased expression of CD44 mRNA | 21865292 |
C061133 | tamibarotene | tamibarotene affects the expression of CD44 mRNA | 15498508 |
C061133 | tamibarotene | tamibarotene results in decreased expression of CD44 mRNA | 17229644 |
D013629 | Tamoxifen | Tamoxifen affects the expression of CD44 mRNA | 14699072 |
C047246 | temozolomide | CD44 mRNA affects the susceptibility to temozolomide | 16365179 |
C501413 | tesaglitazar | tesaglitazar results in decreased expression of CD44 mRNA | 21515302 |
D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CD44 mRNA | 19619570 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CD44 mRNA | 19619570|2010694 |
D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD44 protein] | 20715097 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CD44 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which affects the expression of CD44 mRNA | 15135321 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which affects the expression of CD44 protein | 15135321 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CD44 mRNA alternative form | 15135321 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CD44 protein alternative form | 15135321 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CD44 mRNA | 15800033|1869160 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CD44 protein | 14718643|1597263 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CD44 mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CD44 mRNA | 22808131 |
D013755 | Tetradecanoylphorbol Acetate | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA] | 15477007 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA | 15477007 |
D013755 | Tetradecanoylphorbol Acetate | Chlorpromazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | Trifluoperazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid]] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] | 9929743 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CD44 mRNA | 25613284 |
C056068 | theaflavin | theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CD44 protein] | 27058323 |
D013853 | Thioacetamide | Thioacetamide results in increased expression of CD44 mRNA | 23411599 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of CD44 mRNA | 23557971 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of CD44 mRNA | 27480279 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased methylation of CD44 gene | 26756918 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of CD44 mRNA | 20133372 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of CD44 mRNA | 28111298 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CD44 mRNA" | 19682533 |
D014212 | Tretinoin | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CD44 mRNA | 15894607 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CD44 mRNA | 15498508|1734921 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CD44 mRNA alternative form | 22391160 |
D014212 | Tretinoin | Tretinoin results in increased expression of CD44 mRNA | 15894607|2193413 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CD44 mRNA | 22498432 |
D014212 | Tretinoin | Tretinoin results in increased expression of CD44 protein | 16724877 |
C012589 | trichostatin A | [3-deazaneplanocin co-treated with trichostatin A] affects the expression of CD44 protein | 18538736 |
C012589 | trichostatin A | trichostatin A inhibits the reaction [Nickel affects the expression of CD44 mRNA] | 14575637 |
C012589 | trichostatin A | trichostatin A results in increased expression of CD44 mRNA | 24935251 |
C012589 | trichostatin A | trichostatin A results in decreased expression of CD44 mRNA | 15901671 |
D014268 | Trifluoperazine | Trifluoperazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] | 9929743 |
C046488 | trimethyltin | trimethyltin results in increased expression of CD44 mRNA | 24002884 |
D014302 | Trinitrobenzenesulfonic Acid | seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CD44 protein] | 11717450 |
D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of CD44 protein | 11717450 |
C001899 | triptolide | triptolide inhibits the reaction [cobaltous chloride results in increased expression of CD44 protein] | 24842335 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of CD44 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CD44 mRNA | 23179753|2352703 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CD44 mRNA | 15901671 |
C066075 | vanadium pentoxide | vanadium pentoxide affects the expression of CD44 mRNA | 17459161 |
C066075 | vanadium pentoxide | vanadium pentoxide affects the expression of CD44 mRNA | 26210822 |
D014640 | Vancomycin | Vancomycin results in increased expression of CD44 mRNA | 18289764 |
D001335 | Vehicle Emissions | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Vehicle Emissions affects the expression of CD44 mRNA] | 17655762 |
D001335 | Vehicle Emissions | Vehicle Emissions affects the expression of CD44 mRNA | 17655762 |
D001335 | Vehicle Emissions | Vehicle Emissions promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of CD44 mRNA] | 17655762 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of CD44 gene | 25560391 |
D014700 | Verapamil | Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid]] | 9929743 |
D014700 | Verapamil | Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein] | 9929743 |
D014747 | Vinblastine | Vinblastine results in increased expression of CD44 mRNA | 20624997 |
C025643 | vinclozolin | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA | 25607892 |
D014750 | Vincristine | Vincristine results in increased expression of CD44 mRNA | 23649840 |
C029297 | vinylidene chloride | vinylidene chloride results in increased expression of CD44 mRNA | 26682919 |
D014801 | Vitamin A | Vitamin A results in increased expression of CD44 protein | 16724877 |
D014810 | Vitamin E | Vitamin E results in decreased expression of CD44 mRNA | 19244175 |
D024483 | Vitamin K 3 | Vitamin K 3 affects the expression of CD44 mRNA | 20829426 |
C111237 | vorinostat | vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CD44 protein] | 26305601 |
C017967 | W 7 | W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] | 9929743 |
D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in increased expression of CD44 mRNA | 15784690 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of CD44 mRNA | 24714768 |
D015054 | Zymosan | Zymosan results in increased expression of CD44 mRNA | 11361220 |
D015054 | Zymosan | Zymosan results in increased expression of CD44 mRNA alternative form | 11361220 |